Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

There remains an urgent need for assays to quantify humoral protective immunity to SARS-CoV-2 to understand the immune responses of COVID-19 patients, evaluate efficacy of vaccine candidates in clinical trials, and conduct large-scale epidemiological studies. The plaque-reduction neutralization test...

Descripción completa

Detalles Bibliográficos
Autores principales: Valcourt, Emelissa J., Manguiat, Kathy, Robinson, Alyssia, Chen, Julie Chih-Yu, Dimitrova, Kristina, Philipson, Clark, Lamoureux, Lise, McLachlan, Elizabeth, Schiffman, Zachary, Drebot, Michael A., Wood, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758721/
https://www.ncbi.nlm.nih.gov/pubmed/33387896
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758721/
https://www.ncbi.nlm.nih.gov/pubmed/33387896
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115294

Ejemplares similares